Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells.
W. Martin Kast(University of Southern California), C J Melief(Leiden University), Bart O. Roep(Immune Regulation (United Kingdom)), Arie C. Voordouw(The Netherlands Cancer Institute), Claire J. P. Boog(The Netherlands Cancer Institute)
Cited by 69
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
|The Journal of Experimental Medicine|2012|670